Celyad Oncology SA
Publication of a Transparency Notification Received From Fortress Investment Group LLC
Regulatory News:
Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency dated December 19, 2023, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 55%, holding 29,358,654 voting rights, i.e. 58.37 % of Celyad Oncology’s voting rights.
Lesen Sie auch
Content of the Notification:
-
Reason of the Notification:
Passive crossing of a threshold
-
Notification by:
A parent undertaking or a controlling person
-
Persons subject to the notification requirement:
Fortress Investment Group LLC - 1345 Avenue of the Americas, New York, NY 10105 United States
CFIP CLYD (UK) Limited - 7 Clarges Street, 4th Floor, London W1J 8AE, United Kingdom
-
Date on which the threshold is crossed:
December 8, 2023
-
Threshold that is crossed (in %):
55
-
Denominator:
50,296,947
- Notified details:
A) Voting Rights |
Previous notification |
After the Transaction |
|||
|
# of voting rights |
# of voting rights |
% of voting rights |
||
Holders of voting rights |
|
Linked to the |
Not linked t |
Linked to |
Not linked to |
Fortress Investment Group LLC |
0 |
0 |
0 |
0.00 % |
0.00 % |
CFIP CLYD (UK) Limited |
22,858,654 |
29,358,654 |
0 |
58.37% |
0.00 % |
Subtotal |